Abstract
Much is known about the pathogenesis of MG. This information has provided a rational basis for treatment of the disease, which is very effective. On the other hand, present treatments are limited by significant adverse effects. Our knowledge of pathogenesis also provides clues for the development of new, effective, but less toxic treatments. In addition, knowledge of the autoimmune mechanisms in MG may be useful in devising better treatments for the many human autoimmune diseases that are less well understood.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 106-110 |
| Number of pages | 5 |
| Journal | Seminars in Neurology |
| Volume | 14 |
| Issue number | 2 |
| State | Published - 1994 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)
Cite this
Myasthenia gravis : Pathogenesis and treatment. / Richman, David P; Agius, M. A.
In: Seminars in Neurology, Vol. 14, No. 2, 1994, p. 106-110.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Myasthenia gravis
T2 - Pathogenesis and treatment
AU - Richman, David P
AU - Agius, M. A.
PY - 1994
Y1 - 1994
N2 - Much is known about the pathogenesis of MG. This information has provided a rational basis for treatment of the disease, which is very effective. On the other hand, present treatments are limited by significant adverse effects. Our knowledge of pathogenesis also provides clues for the development of new, effective, but less toxic treatments. In addition, knowledge of the autoimmune mechanisms in MG may be useful in devising better treatments for the many human autoimmune diseases that are less well understood.
AB - Much is known about the pathogenesis of MG. This information has provided a rational basis for treatment of the disease, which is very effective. On the other hand, present treatments are limited by significant adverse effects. Our knowledge of pathogenesis also provides clues for the development of new, effective, but less toxic treatments. In addition, knowledge of the autoimmune mechanisms in MG may be useful in devising better treatments for the many human autoimmune diseases that are less well understood.
UR - http://www.scopus.com/inward/record.url?scp=0028108470&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028108470&partnerID=8YFLogxK
M3 - Article
C2 - 7984824
AN - SCOPUS:0028108470
VL - 14
SP - 106
EP - 110
JO - Seminars in Neurology
JF - Seminars in Neurology
SN - 0271-8235
IS - 2
ER -